Valbiotis' Combined General Meeting on May 27, 2021 Will Exceptionally Be Held Behind Closed Doors

Regulatory News:

Valbiotis (Paris:ALVAL) (FR0013254851 – ALVAL, PEA / SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases, announces that, exceptionally, its Combined General Meeting will be held behind closed doors. It will take place without the physical presence of shareholders and other persons entitled to attend, whether physically or by telephone or audiovisual conference, on May 27, 2021 at 5:00 p.m., in accordance with the regulations relating to combating the spread of the Covid-19 epidemic (Article 4 of French Government Ordinance No. 2020-321 of March 25, 2020, extended by Ordinance No. 2020-1497 of December 2, 2020 and Decree No. 2020-1614 of December 18, 2020 and Decree No. 2021-255 of March 9, 2021).

All the documents relating to the Combined General Meeting of May 27, 2021, as well as the voting form, are available on the Valbiotis website as of today in the following section: www.valbiotis.com/en/annual-general-meeting/

General Meeting participation and voting procedures

In accordance with Article 4 of Ordinance No. 2020-321 of March 25, 2020, extended by Ordinance No. 2020-1497 of December 2, 2020 and Decree No. 2020-1614 of December 18, 2020, and Decree No. 2021-255 of March 9, 2021, the Company's Combined General Meeting of May 27, 2021, upon the decision of the Board of Directors, will be held without the presence of shareholders and other persons entitled to participate in the meeting, whether physically or by telephone or audiovisual conference.

Shareholders may choose one of the following three options:

1. Give a proxy to another shareholder, to their spouse or civil union partner, or to any individual or legal entity of their choice under the legal and regulatory conditions set forth in Articles L. 225-106 of the French Commercial Code;
2. Issue a proxy to the Company without indicating a mandate;
3. Vote by correspondence.

Shareholders will be able to vote by correspondence or give a proxy to the Chairman or to a named person (who will then have to send a vote by correspondence), using the voting form provided for this purpose. These are the only means of participation available to shareholders.